Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans
Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans: A Phase 2, Single-Center, 20-week, Open-Label, Randomized Controlled Trial.
Sponsor: Sundeep Khosla, M.D.
This PHASE2 trial investigates Healthy and is currently completed. Sundeep Khosla, M.D. leads this study, which shows 13 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE2
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
Nov 2023 — Apr 2024 [monthly]
Active Not Recruiting PHASE2
▶ Show 8 earlier versions
-
Jul 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE2
-
Apr 2023 — Jul 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2022 — Apr 2023 [monthly]
Recruiting PHASE2
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2020 — Jun 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sundeep Khosla, M.D.
For direct contact, visit the study record on ClinicalTrials.gov .